SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Bill Wexler's Profits of DOOM
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: xcr600 who wrote (4333)2/3/1999 1:22:00 AM
From: Bill Wexler  Read Replies (1) of 4634
 
Unbelievable. So let me get this straight:

1) Vasomax sales are negligible in Mexico (How many stories have you heard of American men running down to Mexico to bring back loads of Vasomax? 'Nuff said)

2) From Zonagen's own clinical trial data, the drug does not work.

3) Even when injected directly into the penis, Phentolamine does not work.

4) Vasomax has not been - and will not be - approved in the U.S.

5) Zonagen has never made any money...for many years.

Yet this schmuck writes a false report which opines that Zonagen will magically earn a buck a share before the end of FY 99.

Yeah right.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News